LENMAKS 10

Drug name: LENMAKS 10
Generic name: Lenvatinib Mesylate Capsules/Lenvatinib Mesylate Capsules/Lenvatinib
Dosage form: Capsules Dosage and administration: For patients with a body weight of less than 60 kg, the recommended daily dose is 8 mg (2 4 mg capsules), once a day; for patients with a body weight of ≥ 60 kg, the recommended daily dose is 12 mg (3 4 mg capsules), once a day. Treatment should be continued until disease progression or intolerable toxic reactions occur.
Packaging specifications: 4mg capsules: 30 capsules/box 10mg capsules: 30 capsules/box Drug category: Tumor Indications:
This product is suitable for patients with unresectable hepatocellular carcinoma who have not received previous systemic treatment. The key study of this product excluded patients with hepatocellular carcinoma who could receive local treatment, and there is no research data available for such patients.
Approval number: 02 L 0823/20, 02 L 0824/20